United States · FDA National Drug Code directory
LACOSAMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-697_bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc
- Product NDC
- 68462-697
- Form
- INJECTION, SOLUTION
- Composition / generic term
- LACOSAMIDE
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260316
- Source listing expiry
- 20271231
Source-listed ingredients
- LACOSAMIDE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (68462-697-30) / 20 mL in 1 VIAL (68462-697-20) · 68462-697-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →